Fig 1.
Initial MR images obtained 3 days after onset (before intravenous immunoglobulin therapy).
A, Axial T2-weighted image (TR/TE, 4700/102) shows no abnormal signal intensity in the brain.
B, Axial diffusion-weighted images (echo-planar imaging; TR/TE, 7000/77; b = 1000) show no apparent restriction of diffusion.